<?xml version="1.0" encoding="UTF-8"?>
<p id="para1880">HCV infection is second to HBV in causing hepatocellular carcinoma and cirrhosis in Taiwan.
 <xref rid="bib109" ref-type="bibr">
  <sup>109</sup>
 </xref> The overall anti-HCV prevalence was 5·5% in 1991–92, and HCV RNA was detectable in 68% of people with anti-HCV.
 <xref rid="bib110" ref-type="bibr">
  <sup>110</sup>
 </xref> Unsafe injections and blood transfusions were the commonest routes of transmission
 <xref rid="bib110" ref-type="bibr">110</xref>, 
 <xref rid="bib111" ref-type="bibr">111</xref> before programmes on safe blood transfusions (after 1992) and harm reduction (after 2005) were introduced to reduce the incidence of HCV.
 <xref rid="bib111" ref-type="bibr">111</xref>, 
 <xref rid="bib112" ref-type="bibr">112</xref>
</p>
